| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
25,250 |
23,332 |
$756K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
3,845 |
3,602 |
$304K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
7,096 |
6,681 |
$218K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,407 |
2,176 |
$109K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,214 |
1,543 |
$60K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,417 |
1,349 |
$45K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,128 |
3,010 |
$40K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
573 |
531 |
$13K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
235 |
215 |
$12K |
| 87634 |
|
72 |
67 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
14 |
14 |
$1K |
| 69210 |
|
25 |
24 |
$420.37 |
| 81003 |
|
620 |
566 |
$156.79 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
14 |
14 |
$149.38 |